U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the three and six months ended June 30, 2026, on…
VSE Corporation (“VSE” or the “Company”) (NASDAQ: VSEC, VSECU), a leading provider of aviation aftermarket distribution and repair services, announced today that it will issue second quarter 2026 results after the market close on Wednesday, August 5, 2026. A conference call will be held on Thursday…
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that it will report its second quarter 2026 financial results and provide recent corporate updates on August 6, 2026, before the opening of U.S. equity markets. The announcement will be followed by a conference call and webcast at 8:00 a.m…
- Strategic collaboration and equity investment will combine Trinity Biotech's AI-native CGM+ wearable biosensor platform with Latch Medical's innovative intradermal drug delivery technology to develop next-generation metabolic health solutions -DUBLIN and WILSONVILLE, Ore., July 22, 2026 (GLOBE NE…
BOSTON, Mass., July 22, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. NasdaqGS:ZVRA (Zevra, or the Company), a commercial-stage company focused on bringing life-changing therapeutics to people living with rare diseases, today announced it will report corporate and financial results for the seco…
Zoetis Inc. (NYSE: ZTS) today announced the commercial launch of Portela® (relfovetmab) in Canada and the European Union (EU) member states. Portela is the first long-acting anti-nerve growth factor (NGF) monoclonal antibody (mAb) therapy for cats, designed to alleviate pain associated with osteoar…
RNS Number : 4406N Equiniti Share Plan Trustees Ltd 22 July 2026 FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code")1. KEY INFORMATION2. POSITIONS OF THE…
Financial services firm Stifel Financial NYSE:SF missed Wall Street’s revenue expectations in Q2 CY2026, with sales falling 25.5% year on year to $956.5 million. Its non-GAAP profit of $1.42 per share was 4.3% above analysts’ consensus estimates.Stifel (SF) Q2 CY2026 Highlights:Chairman and Chief E…
Leveraging SunTrax Air's purpose-built testing environment, the initiative will help shape the infrastructure and operational framework needed to support Advanced Air Mobility and future commercial eVTOL operations.FARNBOROUGH, England, July 22, 2026 /PRNewswire/ -- Eve Air Mobility ("Eve") (NYSE:E…
RNS Number : 4404N Aberdeen Group PLC 22 July 2026 FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code")1. KEY INFORMATION2. POSITIONS OF THE PERSON MAKING…
US stock futures edged lower on Wednesday as investors pulled back from semiconductor shares before Alphabet and Tesla open the first major test of the second-quarter Big Tech earnings season.Nasdaq 100 contracts led the retreat, while S&P 500 and Dow futures also slipped after Tuesday’s chip-led r…
RNS Number : 4402N Bowbell Master Issuer PLC 22 July 2026 Bowbell Master Issuer PLCReport and Financial StatementsYear ended 31 December 2025A copy of the above document has been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk…
New integration connects institutional algos, block trading and retail distribution to Kalshi's prediction and perpetual marketsNEW YORK, July 22, 2026 /PRNewswire/ -- Talos, the premier provider of institutional digital asset infrastructure, technology and data supporting the full investment lifec…
RNS Number : 4403N L&G – Asset Management Limited 22 July 2026 FORM 8.3PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code")1. KEY INFORMATION2. POSITIONS OF THE PERSON MAKING THE DISCLOSUREIf…
Record quarterly results with EPS of $0.65, net income up 101% year-over-year, and strong loan and deposit growth. Capital position remains robust, with $163 million returned to shareholders and stable credit quality. Positive outlook for 2026 with continued operating leverage.Original document: Ol…
Record Q2 2026 results with 9.8% sales growth, 20.8% higher non-GAAP EPS, and strong cash flow. Digital Imaging led segment growth, and full-year EPS guidance was raised. Net debt declined after a $450 million debt repayment.Original document: Teledyne Technologies Incorporated [TDY] SEC 8-K Curren…
Shares of crypto-linked companies traded lower in pre-market trade on Wednesday, tracking a broader sell-off in U.S. equities after oil prices climbed to a five-week high, with Brent crude pushing past $95 a barrel, amid the ongoing conflict between the U.S. and Iran.Robinhood (HOOD), Coinbase (COI…
Net revenue for 2Q26 was R$10.1 billion, down 0.6% year-over-year, with EBITDA of R$2.2 billion and net income of R$1.56 billion. External markets drove growth, offsetting weaker domestic solar demand, while ROIC improved to 33.6%.Original document: WEG SA [WEGE3] Earnings Release — Jul. 23 2026Thi…
Consolidated service revenue rose 8% and adjusted EBITDA grew 3% year-over-year, while net loss was driven by a $1,034 million non-cash loss on the MLSE put liability. The company reaffirmed 2026 guidance and expects to close the MLSE minority stake acquisition in Q4.Original document: Rogers Commu…
Financial derivatives exchange CME Group NASDAQ:CME reported Q2 CY2026 results topping the market’s revenue expectations, but sales were flat year on year at $1.71 billion. Its non-GAAP profit of $2.99 per share was 2.8% above analysts’ consensus estimates.CME Group (CME) Q2 CY2026 Highlights:Compa…
